Anil D’Cruz

Specialty: Surgical Oncology (Head & Neck Oncology)

Location: Mumbai, Maharashtra, India

Tier: ELITE

H-Index: 110

Years Active: 35

Hospital Affiliations

• Apollo Hospitals - Director of Oncology
• Tata Memorial Hospital - Director (Former)

Techniques Invented

• Defined standard of care for Node-negative Oral Cancer via landmark NEJM study

Key Publications

1. "Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer." - N Engl J Med (2015)
2. "Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial." - J Clin Oncol (2018)
3. "A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer." - Cancer (2019)
4. "Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer." - J Clin Oncol (2022)
5. "Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline." - J Clin Oncol (2019)

Knowledge Graph Relationships

Anil D’Cruz is a Surgical Oncology specialist affiliated with Apollo Hospitals, Tata Memorial Hospital. Invented techniques: Defined standard of care for Node-negative Oral Cancer via landmark NEJM study. Authored 5 scholarly articles.